Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular genetics in acute leukemia.

J D Rowley1

  • 1Section of Hematology/Oncology, University of Chicago Medical Center, IL 60637-1740, USA.

Leukemia
|March 17, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

No chromosome arm unturned: in memory of Roland Berger 1934-2012.

Leukemia·2014
Same author

Broadband terahertz pulse emission from ZnGeP2.

Optics letters·2012
Same author

Differential expression of TCL1 during pre-B-cell acute lymphoblastic leukemia progression.

Cancer genetics and cytogenetics·2002
Same author

Chromosome translocations: dangerous liaisons revisited.

Nature reviews. Cancer·2002
Same author

The pattern of gene expression in human CD34(+) stem/progenitor cells.

Proceedings of the National Academy of Sciences of the United States of America·2001
Same author

The pattern of gene expression in mouse Gr-1(+) myeloid progenitor cells.

Genomics·2001
Same journal

Evolutionary considerations for risk stratification in TP53-variant myeloproliferative neoplasms.

Leukemia·2026
Same journal

Measurable residual disease is not a universally reliable surrogate for progression-free survival in clinical trials of new chronic lymphocytic leukemia therapies.

Leukemia·2026
Same journal

Mantle cell lymphoma artificial intelligence prognostic index using hematoxylin and eosin histology.

Leukemia·2026
Same journal

Redefining light-chain smoldering multiple myeloma: prevalence and progression risk.

Leukemia·2026
Same journal

Decreased TXNRD1 is associated with resistance to tagraxofusp in blastic plasmacytoid dendritic cell neoplasms, as seen in phase II.

Leukemia·2026
Same journal

Retroperitoneal bulk predicts chylothorax in follicular lymphoma-control requires systemic response.

Leukemia·2026
See all related articles

Identifying chromosome changes and gene alterations in acute leukemias improves treatment. Targeting specific genetic changes allows for more precise, subtype-specific therapies for leukemia patients.

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • Advances in identifying chromosomal aberrations and gene mutations in acute leukemias have significantly improved therapeutic strategies.
  • Consistent cytogenetic abnormalities provide precise targets for gene location and subtype-specific leukemia treatments.

Discussion:

  • Translocations are frequent cytogenetic abnormalities in human leukemia, with prevalence varying by age.
  • Leukemias are recognized as genetic diseases, necessitating genotype-specific therapies tailored to individual genetic alterations.

Key Insights:

  • Improved techniques for identifying chromosome changes and affected genes enhance acute leukemia treatments.
  • Targeting specific gene locations based on consistent chromosomal alterations enables focused therapies for leukemia subtypes.

Related Experiment Videos

Outlook:

  • Future research will continue to refine genotype-specific therapies for leukemia.
  • Understanding the genetic basis of leukemia is crucial for developing personalized treatment approaches.